Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 46% ± 19% | |
peripheral blood | 14 studies | 26% ± 8% | |
intestine | 10 studies | 38% ± 20% | |
kidney | 9 studies | 39% ± 13% | |
brain | 9 studies | 30% ± 8% | |
eye | 8 studies | 36% ± 16% | |
liver | 7 studies | 26% ± 17% | |
pancreas | 5 studies | 52% ± 25% | |
uterus | 5 studies | 41% ± 21% | |
placenta | 4 studies | 52% ± 24% | |
bone marrow | 4 studies | 25% ± 8% | |
prostate | 4 studies | 34% ± 10% | |
breast | 4 studies | 36% ± 5% | |
adrenal gland | 3 studies | 26% ± 7% | |
esophagus | 3 studies | 57% ± 27% | |
skin | 3 studies | 31% ± 2% | |
thymus | 3 studies | 46% ± 11% | |
lymph node | 3 studies | 48% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4618.31 | 1445 / 1445 | 100% | 36.18 | 183 / 183 |
kidney | 100% | 6199.07 | 89 / 89 | 100% | 45.93 | 901 / 901 |
ovary | 100% | 4511.21 | 180 / 180 | 100% | 37.55 | 430 / 430 |
stomach | 100% | 3032.84 | 359 / 359 | 100% | 38.18 | 286 / 286 |
uterus | 100% | 3935.41 | 170 / 170 | 100% | 48.19 | 459 / 459 |
brain | 100% | 6037.54 | 2641 / 2642 | 100% | 70.62 | 705 / 705 |
thymus | 100% | 6450.64 | 653 / 653 | 100% | 42.69 | 604 / 605 |
lung | 100% | 4397.16 | 577 / 578 | 100% | 42.49 | 1155 / 1155 |
intestine | 100% | 4202.36 | 966 / 966 | 100% | 40.59 | 526 / 527 |
bladder | 100% | 3815.95 | 21 / 21 | 100% | 47.27 | 503 / 504 |
prostate | 100% | 4809.11 | 245 / 245 | 100% | 46.73 | 501 / 502 |
breast | 100% | 4256.09 | 459 / 459 | 100% | 49.28 | 1115 / 1118 |
adrenal gland | 100% | 5745.07 | 258 / 258 | 99% | 43.53 | 228 / 230 |
skin | 100% | 3995.70 | 1804 / 1809 | 99% | 48.95 | 467 / 472 |
pancreas | 99% | 1926.09 | 325 / 328 | 99% | 35.75 | 177 / 178 |
liver | 100% | 1966.02 | 225 / 226 | 98% | 18.80 | 397 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 26.29 | 29 / 29 |
spleen | 100% | 3893.04 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 38.05 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 42.69 | 1 / 1 |
adipose | 100% | 3569.39 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 2669.27 | 799 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 3140.98 | 1327 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 3857.63 | 852 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 25.73 | 79 / 80 |
peripheral blood | 81% | 1904.60 | 756 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035987 | Biological process | endodermal cell differentiation |
GO_0070370 | Biological process | cellular heat acclimation |
GO_0019896 | Biological process | axonal transport of mitochondrion |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_1904115 | Cellular component | axon cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | HSBP1 |
Protein name | Heat shock factor-binding protein 1 Heat shock factor-binding protein 1 (Nasopharyngeal carcinoma-associated antigen 13) (NPC-A-13) |
Synonyms | HSF1BP |
Description | FUNCTION: Negative regulator of the heat shock response. Negatively affects HSF1 DNA-binding activity. May have a role in the suppression of the activation of the stress response during the aging process. FUNCTION: Negative regulator of the heat shock response. Negatively affects HSF1 DNA-binding activity. May have a role in the suppression of the activation of the stress response during the aging process. . FUNCTION: Negative regulator of the heat shock response. Negatively affects HSF1 DNA-binding activity. May have a role in the suppression of the activation of the stress response during the aging process. . |
Accessions | ENST00000685468.1 ENST00000433866.7 A0A8I5KTJ3 A0A8I5KYC9 O75506 ENST00000689426.1 ENST00000570259.1 |